[
    [
        {
            "time": "",
            "original_text": "泰格医药拟港联所挂牌，为国内CRO企业A+H第三家",
            "features": {
                "keywords": [
                    "泰格医药",
                    "港联所",
                    "挂牌",
                    "CRO企业",
                    "A+H"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药拟港联所挂牌，为国内CRO企业A+H第三家",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]